Pathogenic loss-of-function variants of the FGFR1 gene were reported to be involved in patients with Kallmann Syndrome, including hypogonadotropic hypogonadism and anosmia [5,10,27], and isolated HH [6,7,8,9]. This evidence concerns the gene FGFR1 and hypogonadotropic hypogonadism.